OpGen, Inc. (NASDAQ:OPGN – Get Free Report) shares passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.02 and traded as high as $1.37. OpGen shares last traded at $1.37, with a volume of 3,716 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com initiated coverage on OpGen in a research note on Thursday. They issued a “sell” rating on the stock.
View Our Latest Stock Analysis on OPGN
OpGen Trading Up 14.2 %
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Read More
- Five stocks we like better than OpGen
- Transportation Stocks Investing
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What is a Death Cross in Stocks?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
